NXTS
Nexentis Technologies Inc. Common Stock
Nasdaq · usd
Nexentis Technologies Inc. Common Stock (NXTS) trades at $1.83 (-8.04%) as of 1:04:37 PM EST on Nov 17, 2026, -41.29% over the past month. Market cap is $945.46K, with 1.0 days to cover in short interest.
Stock performance
How Nexentis Technologies Inc. Common Stock (NXTS) stock has performed from one day to one year, with its 52-week range.
- 1D
- -5.53%
- 1W
- -26.56%
- 1M
- -41.29%
- YTD
- -94.79%
- 1Y
- -94.79%
- 52-wk range
- $1.82 – $119.00
Key statistics
Today's trading snapshot for NXTS: day range, open, previous close, volume and market cap.
- Day range
- $1.82 – $1.92
- Open
- $1.92
- Prev close
- $1.99
- Volume
- 4.39K
- Market cap
- $945.46K
- Shares out
- 475.1K
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Nexentis Technologies Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 524.99
- P/B
- 0.46
- P/FCF
- —
- ROE
- -755.3%
- ROA
- -92.5%
- Debt/Equity
- 0.18
- Div yield
- 0.00%
As of Nov 13, 2026
8-K filings
Material corporate events Nexentis Technologies Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Equity compensation grantNov 10, 2026
On November 9, 2026, Nexentis Technologies Inc. (the "Company") issued 72,000 shares of common stock to consultants in consideration of various investor relations and business development services provided to the Company. The issuance of such shares was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof as transactions by an issuer not involving a public offering.
- Charter amendmentNov 6, 2026
The Company filed with the Secretary of State of the State of Nevada a Certificate of Amendment to its Articles of Incorporation, as amended ... to effect the Reverse Stock Split.
- Equity compensation grantOct 19, 2026
On October 15, 2026, Nexentis Technologies Inc. issued ... 51,000 shares of common stock to a consultant for accounting and controller services ...; (ii) 101,549 shares ... to David Palach, its Chief Executive Officer; (iii) 51,000 shares ... to Lital Barda, its Chief Financial Officer; (iv) an aggregate of 208,639 shares ... to the Company's directors, in each case under its 2022 Share Incentive Plan.
- Listing deficiency noticeSep 3, 2026
On August 31, 2026, Nexentis Technologies Inc. received a letter from the Listing Qualifications Staff of The Nasdaq Capital Market notifying the Company that its stockholders' equity was no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. As reported on the Form 10-Q, the Company's stockholders' equity as of June 30, 2026 was $1,782,000.
- Auditor dismissalAug 6, 2026
On August 6, 2026, the board of directors (the "Board") and audit committee of the Board (the "Audit Committee") of Nexentis Technologies Inc. (the "Company") approved the dismissal of Somekh Chaikin, a member firm of KPMG International ("KPMG Israel"), as its independent registered public accounting firm, effective on August 6, 2026.
Dividend history and stock splits
Nexentis Technologies Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-5Nov 9, 2026
- 1-for-7Apr 8, 2026
NXTS short interest
How heavily NXTS is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 63.64K
- Avg volume
- 331.23K
As of · reported to FINRA twice monthly.
NXTS news
The latest news and headlines about Nexentis Technologies Inc. Common Stock (NXTS).
- Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory BoardpositiveGlobeNewswire Inc.· Sep 24, 2026
Frequently asked questions
What is the Nexentis Technologies Inc. Common Stock (NXTS) stock price today?
Nexentis Technologies Inc. Common Stock (NXTS) is trading at $1.83 (-8.04% on the day) as of 1:04:37 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Nexentis Technologies Inc. Common Stock?
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and…
What is the short interest in NXTS?
As of Oct 30, 2026, NXTS has 63.64K shares short and 1.0 days to cover.
What exchange is NXTS listed on?
Nexentis Technologies Inc. Common Stock (NXTS) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of NXTS with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NXTS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.